Abbreviations
- CCR :
-
Cancer ColoRectal
- CIMP + :
-
Cpg-Island Methylator Phenotype +
- CpG :
-
Cytosine-phosphate-Guanine
- EXO1 :
-
EXOnuclease 1
- HNPCC :
-
Hereditary NonPolyposis Colorectal Cancer
- ICG-HNPCC :
-
International Collaborative Group on Hereditary NonPolyposis Colorectal Cancer
- IHC :
-
ImmunoHistoChimie
- InSiGHT :
-
International Society for Gastrointestinal Hereditary Tumors
- MLH1 (ou hMLH1) :
-
MutL,E. coli, human Homolog 1
- MMR :
-
MisMatch Repair »i.e. réparation des mésappariements de l’ADN
- MSH2 (ou hMSH2) :
-
MutS,E. coli, human Homolog 2
- MSH6 (ou hMSH6) :
-
MutS,E. coli, human Homolog 6
- MSI :
-
MicroSatellite Instability
- MSI-H :
-
MSI «High»
- MSI-L (ou MSI -) :
-
MSI «Low»
- MSS :
-
MicroSatellite Stable
- MYH :
-
Mut Y human Homolog
- PAF :
-
Polypose Adénomateuse Familiale
- PMS1 :
-
PostMeiotic Segregation increased,S. cerevisiae, 1
- PMS2 :
-
PostMeiotic Segregation increased,S. cerevisiae, 2
- RER :
-
Replication ERrors
- TGFß-R2 :
-
Transforming Growth Factor ß-Receptor 2
- CRC :
-
ColoRectal Cancer
- CIMP + :
-
Cpg-Island Methylator Phenotype +
- CpG :
-
Cytosine-phosphate-Guanine
- EXO1 :
-
EXOnuclease 1
- HNPCC :
-
Hereditary NonPolyposis Colorectal Cancer
- ICG-HNPCC :
-
International Collaborative Group on Hereditary NonPolyposis Colorectal Cancer
- IHC :
-
ImmunoHistoChemistry
- InSiGHT :
-
International Society for Gastrointestinal Hereditary Tumors
- MLH1 (o hMLH1) :
-
MutL,E. coli, human Homolog1
- MMR :
-
MisMatch
- MSH2 (or hMSH2) :
-
MutS,E. coli, human Homolog 2
- MSH6 (or hMSH6) :
-
MutS,E. coli, human Homolog 6
- MSI :
-
MicroSatellite Instability
- MSI-H (or MSI +) :
-
MSI High
- MSI-L (or MSI -) :
-
MSI Low
- MSS :
-
MicroSatellite Stable
- MYH :
-
Mut Y human Homolog
- FAP :
-
Familial Adenomatous Polyposis
- PMS1 :
-
PostMeiotic Segregation increased,S. cerevisiae, 1
- PMS2 :
-
PostMeiotic Segregation increased,S. cerevisiae, 2
- RER :
-
Replication ERrors
- TGFß-R2 :
-
Transforming Growth Factor ß-Receptor 2
Références
Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush AJ. Hereditary factors in cancer. Study of two large midwestern kindreds. Arch Intern Med 1966;117:206–12.
Warthin AS. Heredity with reference to carcinoma. Arch Intern Med 1913;12:546–55.
Lynch HT, Krush AJ. Cancer family “G” revisited: 1895–1970. Cancer 1971;27:1505–11.
Douglas JA, Gruber SB, Meister KA, et al. History and molecular genetics of Lynch syndrome in family G: a century later. JAMA 2005;294:2195–202.
Lynch HT, Lynch JF. Lynch syndrome: history and current status. Dis Markers 2004; 20:181–98.
Cantor D. The frustrations of families: Henry Lynch, heredity, and cancer control, 1962–1975. Med Hist 2006;50:279–302.
Boland CR. Evolution of the nomenclature for the hereditary colorectal cancer syndromes. Fam Cancer 2005;4:211–8.
Necochea R. From cancer families to HNPCC: Henry Lynch and the transformations of hereditary cancer, 1975–1999. Bull Hist Med 2007;81:267–85.
Lynch HT, Cristofaro G, Rozen P. et al. History of the International Collaborative Group on Hereditary Non Polyposis Colorectal Cancer. Fam Cancer 2003;2:3–5.
Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34:424–5.
Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999;116:1453–6.
Rodriguez-Bigas MA, Boland CR, Hamilton SR. et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997;89:1758–62.
Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816–9.
Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993; 363:558–61.
Peltomaki P, Aaltonen LA, Sistonen P. et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 1993;260:810–2.
Lindblom A. Tannergard P, Werelius B, Nordenskjold M. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nat Genet 1993;5:279–82.
Fishel R, Lescoe MK, Rao MR. et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027–38.
Leach FS, Nicolaides NC, Papadopoulos N. et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215–25.
Lynch HT, Coronel SM, Okimoto R. et al. A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States. JAMA 2004;291:718–24.
Lynch HT, Lynch JF, Lynch PM. Toward a consensus in molecular diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome). J Natl Cancer Inst 2007;99:261–3.
Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003; 348:919–32.
Umar A. Boland CR, Terdiman JP. et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004;96:261–8.
Syngal S, Fox EA, Eng C, Kolodner RD, Garber JE. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer-associated mutations in MSH2 and MLH1. J Med Genet 2000;37:641–5.
Schischmanoff PO, Lagorce C, Wind P, Benamouzig R. Le syndrome HNPCC (Hereditary Non Polyposis Colon Cancer). Diagnostic et prise en charge Gastroenterol Clin Biol 2005;29:1028–34.
Hampel H, Frankel WL, Martin E. et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005;352:1851–60.
Olschwang S, Bonaiti C, Feingold J. et al. Identification et prise en charge du syndrome HNPCC (hereditary non polyposis colon cancer). Bull Cancer 2004;91:303–15.
De Felice C, Gentile M, Barducci A. et al. Abnormal oral mucosal light reflectance: a new clinical marker of high risk for colorectal cancer. Gut 2006;55:1436–9.
Olschwang S, Paraf F, Laurent-Puig P. et al. Contributions récentes pour l’identification et le dépistage du syndrome de Lynch. Gastroenterol Clin Biol 2007;31:136–40.
Fridrichova I. New aspects in molecular diagnosis of Lynch syndrome (HNPCC). Cancer Biomark 2006;2:37–49.
Hitchins MP, Wong JJ, Suthers G et al. Inheritance of a cancer-associated MLH1 germ-line epimutation. N Engl J Med 2007;356:697–705.
Peltomaki P, Vasen H. Mutations associated with HNPCC predisposition — Update of ICG-HNPCC/INSiGHT mutation database. Dis Markers 2004; 20:269–76.
Lagerstedt-Robinson K, Liu T, Vandrovcova J. et al. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst 2007;99:291–9.
Lynch HT, Lynch JF. What the physician needs to know about Lynch syndrome: an update. Oncology (Williston.Park) 2005;19:455–63.
Hampel H, Stephens JA, Pukkala E. et al. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 2005;129:415–21.
Vasen HF, Moslein G, Alonso A. et al. Guidelines for the clinical management of Lynch syndrome (HNPCC). J Med Genet 2007; 44: 353–62.
Ramsey SD, Clarke L, Etzioni R, Higashi M, Berry K, Urban N. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer. Ann Intern Med 2001;135:577–88.
Lindor N.M., Petersen G.M., Hadley D.W. et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006;296:1507–17.
Guimbaud R. Indications et intérêts de la consultation d’oncogénétique. Gastroenterol Clin Biol 2005;29:711–4.
Lindor NM, Rabe K, Petersen GM. et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005;293:1979–85.
Jarvinen HJ, Aarnio M, Mustonen H. et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000;118:829–34.
Kiesslich R, Neurath MF. Screening and early diagnosis of colorectal cancer. Acta Endocopica 2007;37:207–29.
DeFrancisco J, Grady W. Diagnosis and management of hereditary non-polyposis colon cancer. Gastrointest Endosc 2003;58:390–408.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Matuchansky, C. Henry Thomson Lynch, un itinéraire exemplaire de la génétique clinique à la biologie moléculaire. Acta Endosc 37, 491–508 (2007). https://doi.org/10.1007/BF02961797
Issue Date:
DOI: https://doi.org/10.1007/BF02961797